Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
CNQX:MDMA
Holding TSE:MDMA?
Track your performance easily
MDMA Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.07 - C$0.35
Previous CloseC$0.34
Volume494.78K
Average Volume (3M)350.94K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)C$495.81K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.13
Next Earnings
Dec 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding95,940,884
10 Day Avg. Volume959,945
30 Day Avg. Volume350,939
Standard Deviation0.56
R-Squared0.00247
Alpha0.13
Financial Highlights & Ratios
Price to Book (P/B)16.75
Price to Sales (P/S)21.60
Price to Cash Flow (P/CF)-33.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PharmAla Biotech Holdings, Inc. News
PremiumCompany Announcements
PharmAla Biotech Secures Data License, Settles Debt
PremiumCompany Announcements
PharmAla Biotech to Supply MDMA for Yale Trial
PremiumCompany Announcements
PharmAla Partners with University for Clinical Trial
PremiumCompany Announcements
PharmAla Biotech Secures Harvard Supply Deal, Eyes European Distribution
PremiumCompany Announcements
PharmAla Biotech Advances with MDMA Supply and ResearchPremiumCompany Announcements
PharmAla Biotech Unveils New MDMA Research PlatformPremiumCompany Announcements
PharmAla Biotech Advances Despite USFDA Setback
PremiumCompany Announcements
PharmAla Biotech Posts Strong Q3 Growth and IP AdvancesOptions Prices
Currently, No data available
---
Ownership Overview
MDMA FAQ
What was PharmAla Biotech Holdings, Inc.’s price range in the past 12 months?
PharmAla Biotech Holdings, Inc. lowest stock price was C$0.07 and its highest was C$0.35 in the past 12 months.
What is PharmAla Biotech Holdings, Inc.’s market cap?
Currently, no data Available
When is PharmAla Biotech Holdings, Inc.’s upcoming earnings report date?
PharmAla Biotech Holdings, Inc.’s upcoming earnings report date is Dec 20, 2024 which is in 29 days.
How were PharmAla Biotech Holdings, Inc.’s earnings last quarter?
PharmAla Biotech Holdings, Inc. released its earnings results on Jul 30, 2024. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is PharmAla Biotech Holdings, Inc. overvalued?
According to Wall Street analysts PharmAla Biotech Holdings, Inc.’s price is currently Overvalued.
Does PharmAla Biotech Holdings, Inc. pay dividends?
PharmAla Biotech Holdings, Inc. does not currently pay dividends.
What is PharmAla Biotech Holdings, Inc.’s EPS estimate?
PharmAla Biotech Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmAla Biotech Holdings, Inc. have?
PharmAla Biotech Holdings, Inc. has 95,940,890 shares outstanding.
What happened to PharmAla Biotech Holdings, Inc.’s price movement after its last earnings report?
PharmAla Biotech Holdings, Inc. reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PharmAla Biotech Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:MDMA
---
PharmAla Biotech Holdings, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
204.54%
12-Months-Change
Fundamentals
Return on Equity
-39.43%
Trailing 12-Months
Asset Growth
26.45%
Trailing 12-Months
Company Description
PharmAla Biotech Holdings, Inc.
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions.
---
Technical Analysis
---